查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577306

生医冰箱与冷冻柜市场、机会、成长动力、产业趋势分析与预测，2024-2032

Biomedical Refrigerators and Freezers Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 87 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球生物医学冰箱和冰柜市场价值约为 37 亿美元，在老年人口不断增长的推动下，预计 2024 年至 2032 年复合年增长率为 5.3%。

世界卫生组织 (WHO) 预测，到 2030 年，全球六分之一的人将年龄在 60 岁或以上。随着全球人口老化，针对老年人的医疗服务、药品和生物製药的需求不断增加。这一人群通常需要全面的医疗治疗，从疫苗和药物到器官移植，这凸显了生物医学冰箱和冰柜实现最佳储存和保存的必要性。此外，与年龄相关的疾病和病症的增加推动了老年护理领域的先进研究和开发，扩大了生物医学领域对顶级储存解决方案的需求。

技术创新不断增强生物医学冰箱和冰柜的功能。增强的冷却技术、节能係统以及复杂的温度监测和控制功能等突破扩大了这些设备的功能和可靠性。此外，生物製药和器官移植需求的激增推动了市场的发展。生物技术的进步促进了生物製药的生产，包括疫苗和基因疗法，这需要严格的温度调节。同时，器官移植需求的不断增加凸显了供体器官可靠储存的重要性。对生物製药和器官移植的高度依赖增加了对最先进的生物医学冷冻系统的需求，推动了市场扩张。

整个生物医​​学冰箱和冰柜行业根据产品、最终用途和地区进行分类。

到 2032 年，实验室冰箱市场预计将达到 16 亿美元。随着全球研究活动的蓬勃发展和实验室不断拥抱技术进步，对可靠、高效的冷冻解决方案的需求不断增加。学术和工业研究资金的增加，加上对精准医学和生物技术的高度关注，进一步增加了对先进实验室冷冻设备的需求。此外，卓越的温度控制、能源效率和直觉的介面等功能的不断发展满足了现代实验室的需求。

2023年，诊断中心部门的估值为14亿美元。慢性病发病率的上升以及对及时、精确诊断的需求不断增加，刺激了对尖端诊断技术和可靠储存解决方案的需求。此外，对预防性医疗保健和常规健康检查的日益重视也扩大了诊断中心对这些设备的需求。随着这些中心的发展和产品范围的扩大，对专业生物医学冰箱和冷冻库的需求将保持强劲。

到2032年，美国生物医学冰箱和冰柜市场预计将达到17亿美元。该行业的成长取决于先进的生物医学冷冻和冷冻解决方案，这对于温度敏感产品的正确储存至关重要，从而推动了该国市场的扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业影响力
    • 成长动力
      • 政府对研究活动和临床试验的支持不断增加
      • 生物医学冰箱和冷冻库的技术进步
      • 老年人口基数不断增加
      • 进步增加了对生物製药和器官移植的需求
    • 产业陷阱与挑战
      • 大量本地企业提供价格实惠的翻新设备
      • 冰箱和冷冻库释放的氢氟碳化合物对环境产生有害影响
      • 生物医学冰箱和冰柜的采购成本、维护成本和能源成本较高
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 定价分析，2021 - 2032
  • 成本结构分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 等离子冷冻机
  • 血库冰箱
  • 实验室冰箱
  • 实验室冰柜
  • 超低温冷冻柜
  • 冷冻柜

第 6 章：市场估计与预测：依最终用途，2021 - 2032 年

  • 主要趋势
  • 血库
  • 药局
  • 医院
  • 研究实验室
  • 诊断中心
  • 其他最终用户

第 7 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 8 章：公司简介

  • Aegis Scientific, Inc.
  • Azbil Corporation
  • B Medical Systems
  • BINDER GmbH
  • Eppendorf SE
  • Follett Products, LLC
  • Helmer Scientific Inc.
  • Lab Research Products
  • Migali Scientific
  • NuAire, Inc.
  • PHC Corporation
  • Powers Scientific, Inc.
  • So-Low Environmental Equipment Co.
  • Stirling Ultracold
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: 822

The Global Biomedical Refrigerators And Freezers Market was valued at approximately USD 3.7 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2032, driven by the rising geriatric population.

The World Health Organization (WHO) forecasts that by 2030, one in six people worldwide will be aged 60 or older. With an aging global populace comes an escalating demand for medical services, pharmaceuticals, and biopharmaceuticals tailored for the elderly. This demographic often requires comprehensive medical treatments, from vaccines and medications to organ transplants, underscoring the necessity of biomedical refrigerators and freezers for optimal storage and preservation. Moreover, the uptick in age-related diseases and conditions fuels advanced research and development in geriatric care, amplifying the demand for top-tier storage solutions in biomedical contexts.

Technological innovations are consistently augmenting the capabilities of biomedical refrigerators and freezers. Breakthroughs like enhanced cooling technologies, energy-efficient systems, and sophisticated temperature monitoring and control features have broadened the functionality and dependability of these devices. Additionally, the surging demand for biopharmaceuticals and organ transplants propels the market. Biotechnology advancements have escalated the production of biopharmaceuticals, including vaccines and gene therapies, which demand meticulous temperature regulation. Concurrently, the escalating need for organ transplants underscores the importance of dependable storage for donor organs. This heightened dependence on biopharmaceuticals and organ transplants amplifies the demand for state-of-the-art biomedical refrigeration systems, driving market expansion.

The overall biomedical refrigerators and freezers industry is classified based on product, end use , and region.

The lab refrigerators segment is projected to hit USD 1.6 billion by 2032. The surging demand for lab refrigerators stems from the increasing need to accurately store biological samples, reagents, and other temperature-sensitive materials vital for research and diagnostics. As global research activities burgeon and laboratories embrace technological advancements, the demand for dependable and efficient refrigeration solutions intensifies. The uptick in funding for academic and industrial research, coupled with a heightened focus on precision medicine and biotechnology, further amplifies the need for sophisticated lab refrigeration equipment. Additionally, the continuous evolution of features like superior temperature control, energy efficiency, and intuitive interfaces caters to the modern laboratory's demands.

The diagnostic centers segment recorded a valuation of USD 1.4 billion in 2023. These centers, which conduct a variety of tests for medical diagnoses, heavily depend on biomedical refrigeration and freezing equipment for storing delicate biological samples, reagents, and pharmaceuticals. The rising incidence of chronic diseases and the heightened demand for timely and precise diagnostics have spurred the need for cutting-edge diagnostic technologies and reliable storage solutions. Furthermore, the growing emphasis on preventive healthcare and routine health screenings has amplified the demand for these devices in diagnostic centers. As these centers evolve and broaden their offerings, the appetite for specialized biomedical refrigerators and freezers is poised to remain robust.

The U.S. biomedical refrigerators and freezers market is on track to reach USD 1.7 billion by 2032. As a front-runner in the global biopharmaceutical arena, the U.S. excels in developing and manufacturing vaccines, biologics, and cutting-edge therapies. The growth of this sector hinges on advanced biomedical refrigeration and freezing solutions, essential for the proper storage of temperature-sensitive products, thus driving market expansion in the nation.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry impact forces
    • 3.1.1 Growth drivers
      • 3.1.1.1 Rising government support for research activities and clinical trials
      • 3.1.1.2 Technological advancements in biomedical refrigerators and freezers
      • 3.1.1.3 Increasing geriatric population base
      • 3.1.1.4 Advances increasing demand for biopharmaceuticals and organ transplantation
    • 3.1.2 Industry pitfalls and challenges
      • 3.1.2.1 Presence of large number of local players providing affordable refurbished equipment
      • 3.1.2.2 Release of hydrofluorocarbons from refrigerators and freezers have deleterious impact on environment
      • 3.1.2.3 High purchase costs, maintenance costs and energy costs of biomedical refrigerators and freezers
  • 3.2 Growth potential analysis
  • 3.3 Regulatory landscape
  • 3.4 Technological landscape
  • 3.5 Pricing analysis, 2021 - 2032
  • 3.6 Cost structure analysis
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Plasma freezers
  • 5.3 Blood bank refrigerators
  • 5.4 Lab refrigerators
  • 5.5 Lab freezers
  • 5.6 Ultra-low temperature freezers
  • 5.7 Shock freezers

Chapter 6 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Blood banks
  • 6.3 Pharmacies
  • 6.4 Hospitals
  • 6.5 Research labs
  • 6.6 Diagnostic centers
  • 6.7 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Aegis Scientific, Inc.
  • 8.2 Azbil Corporation
  • 8.3 B Medical Systems
  • 8.4 BINDER GmbH
  • 8.5 Eppendorf SE
  • 8.6 Follett Products, LLC
  • 8.7 Helmer Scientific Inc.
  • 8.8 Lab Research Products
  • 8.9 Migali Scientific
  • 8.10 NuAire, Inc.
  • 8.11 PHC Corporation
  • 8.12 Powers Scientific, Inc.
  • 8.13 So-Low Environmental Equipment Co.
  • 8.14 Stirling Ultracold
  • 8.15 Thermo Fisher Scientific Inc.